DUBLIN, Ohio, Feb. 3, 2012 (HSMN NewsFeed) -- Today Cardinal Health was granted a temporary restraining order against the Drug Enforcement Administration's (DEA) immediate suspension order of its Lakeland, Fla. DEA registration. U.S. District Court fo...
Biopharmaceuticals, Distribution
Cardinal Health

SAN DIEGO, Feb. 3, 2012 (HSMN NewsFeed) -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the appointment of Anthony J. Yost as Senior Vice President and Chief Commercial Officer. Tony joins Prometheus...
Diagnostics, Personnel
Prometheus Laboratories

* Threshold to receive $25 million upfront, plus further potential milestones and royalties * Deal provides Threshold option to co-commercialize in the United States * Phase 3 trial in soft tissue sarcoma on-going and randomized Phase II trial in pat...
Biopharmaceuticals, Oncology
Threshold Pharmaceuticals, Merck KGaA, TH-302, soft tissue sarcoma

Company to Provide Same High-Quality Anatomic Pathology Services Under New Name TOKYO and IRVING, Texas, Feb. 3, 2012 --(HSMN NewsFeed) -- Caris Diagnostics, specializing in academic-caliber anatomic pathology services, today announced a company name ch...
Diagnostics
Miraca Life Sciences, Caris Diagnostics

Leveraging 25-Plus Years Diagnostic Industry Experience, Andrews Will Shape Life Technologies Molecular Diagnostics Business CARLSBAD, Calif., Feb. 2, 2012 (HSMN NewsFeed) -- Life Technologies Corporation (NASDAQ: LIFE ) today announced that Ronnie An...
Diagnostics, Personnel
Life Technologies

Results Provide Basis for Landmark EXCITE ISR Trial Underway in United States COLORADO SPRINGS, Colo.--(Healthcare Sales & Marketing Network)-- Spectranetics Corporation (Nasdaq:SPNC ) today announced six month interim results from the PATENT (Photo-Abl...
Devices, Interventional
Spectranetics, PATENT study, peripheral in-stent restenosis, laser atherectomy

One treatment procedure primed to propel facial aesthetic procedures forward with unique results and significant science IRVINE, Calif., Feb. 2, 2012 (HSMN NewsFeed) -- Syneron Medical Ltd. (NASDAQ: ELOS ), www.syneron.com, the global leader in medica...
Devices, Dermatology
Syneron Medical, evolastin procedure

LANGHORNE, Pennsylvania and OXFORD, England, February 2, 2012 (HSMN NewsFeed) --EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has acquired the exclus...
Biopharmaceuticals, Oncology, Acquisitions
EUSA Pharma, Alizé Pharma, ASPAREC , acute lymphoblastic leukemia

Platinum chromium coronary stent with enhanced delivery system now available in Europe and other international countries NATICK, Mass., Feb. 1, 2012 (HSMN NewsFeed) -- Boston Scientific Corporation (NYSE: BSX ) announces first patient use and European...
Devices, Interventional Cardiology
Boston Scientific, PROMUS Element, Platinum Chromium, drug eluting stent

New LipiFlow® System Provides Enhanced Graphical User Interface and Ability to Perform Bilateral Treatment from a Single Device MORRISVILLE, N.C.--(Healthcare Sales & Marketing Network)-- TearScience, Inc., a privately-held medical device company, t...
Devices, Ophthalmology, FDA
TearScience, LipiFlow, Thermal Pulsation System, dry eye

John H. Johnson Elected President, Chief Executive Officer and Chairman-Elect, Dr. Mitchell H. Gold Elected Executive Chairman Company to Hold Conference Call Today at 9:00 a.m. ET/6:00 a.m. PT SEATTLE--(Healthcare Sales & Marketing Network)-- Febr...
Biopharmaceuticals, Personnel
Dendreon

New Addition to the Aquilion CT Product Family Offers Ultra-Low Dose and Ultra-Fast Workflow TUSTIN, Calif.--(Healthcare Sales & Marketing Network)-- Toshiba America Medical Systems, Inc. announces the FDA clearance of the Aquilion™ PRIME CT system, the...
Devices, Radiology, FDA
Toshiba America Medical Systems, Aquilion PRIME

Phase III results showed 54% reduction in risk of recurrence and 55% reduction in risk of death after three years' adjuvant Gleevec in adults with KIT+ GIST(1) Approval builds on vast experience with Gleevec, first approved 10 years ago for treatment of...
Biopharmaceuticals, Oncology, FDA
Novartis, Gleevec, imatinib, gastrointestinal stromal tumor

TEL AVIV, Israel--(Healthcare Sales & Marketing Network)-- CartiHeal (2009), Ltd, a privately held medical device company, focused on developing and bringing to market a proprietary, off-the-shelf, and cell-free cartilage regeneration technology, announced...
Devices, Orthopaedic, Venture Capital
CartiHeal, Agili-C, Cartilage Regeneration

NEEDHAM, MA -- (Healthcare Sales & Marketing Network) -- Vita Needle Company recently celebrated dual certifications of its Quality Management Systems to the latest general ISO 9001:2008 and medical device manufacturing standards ISO 13485:2003. In addit...
Devices, Regulatory
Vita Needle

Fog-Reduction Technology, "Cinch-And-Hug" Single-Tie Design Provide Highest Level of Protection DUBLIN, Ohio, Jan. 31, 2012 (HSMN NewsFeed) -- Cardinal Health today announced the availability of its Smart-Seal™ surgical mask, designed to enh...
Devices, Surgery
Cardinal Health, Smart-Seal, surgical mask

AngioDynamics to host conference call today at 11:30 am ET Increases Scale in Vascular Access and Peripheral Vascular Markets Expands Product Portfolio and Adds Innovative Technologies Strengthens Focus on Operational Excellence Expected to be ...
Devices, Mergers & Acquisitions
AngioDynamics, Navilyst Medical

New lead portfolio combined with Sorin Group’s innovative and intelligent devices provide full-featured systems for accurate management of arrhythmias and heart failure MILAN--(Healthcare Sales & Marketing Network)-- Sorin Group, (MIL:SRN.MI ) (Reuters ...
Devices, Cardiology, Regulatory
Sorin Group, pacing leads, TILDA pacing leads, VIGILA defibrillation leads

LEEDS, England, January 31, 2012 (HSMN NewsFeed) -- UK surgical sealant film company Tissuemed Ltd. has announced the publication of a new clinical paper in World Neurosurgery relating to its self-adhesive dural sealant film products. Authored by Dr P...
Devices, Neurosurgery
Tissuemed, dural sealant film, TissuePatchDural

LAKE FOREST, Ill., Jan. 30, 2012 (HSMN NewsFeed) -- Hospira, Inc. (NYSE: HSP ), the world's leading provider of injectable drugs and infusion technologies, today announced that Richard Davies has been named senior vice president and chief commercial offi...
Biopharmaceuticals, Drug Delivery, Personnel
Hospira